Clinical implications of cigarette smoking in acute myocardial infarction: Acute angiographic findings and long-term prognosis

https://doi.org/10.1016/S0002-8703(97)80020-8Get rights and content

This study was undertaken to assess whether reperfusion in smokers could be achieved spontaneously or therapeutically and to assess whether favorable outcome in smokers could be sustained for years after infarction. We studied 260 patients with anterior myocardial infarction who underwent coronary angiography and thrombolysis within 24 hours after the onset of chest pain. There were 158 smokers and 102 nonsmokers. Smoking was associated more with men, younger age, and less multivessel disease. On initial angiography, the distribution of Thrombolysis in Myocardial Infarction grade was similar between smokers and nonsmokers. After thrombolysis, Thrombolysis in Myocardial Infarction grade 3 was more frequent in smokers (32% vs 18%; p=0.004). In-hospital mortality rates were lower (8% vs 18%; p=0.022) and long-term cardiac survival was better in smokers (5-year survival: 82% vs 70%; p=0.022). Our data demonstrated that the infarct artery of smokers responded more efficiently to thrombolysis and favorable outcome in smokers was sustained throughout 5 years.

References (21)

There are more references available in the full text version of this article.

Cited by (32)

  • Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary Intervention

    2018, American Journal of Cardiology
    Citation Excerpt :

    Smokers tend to present with AMI in younger age than nonsmokers. They have lower co-morbidities because of young age.1,2 They tend to quit smoking as they age and develop other cardiovascular risk factors.23

  • No correlation between body mass index and 30-day prognostic outcome in Asians with acute ST-elevation myocardial infarction undergoing primary coronary intervention

    2017, Biomedical Journal
    Citation Excerpt :

    Intriguingly, the paradoxical effects of smoking and higher blood pressure on better prognostic outcome in acute coronary syndrome patients have also been reported in some previous studies [39–42]. Tentative explanations for these paradoxical effects have been identified [16,23–28,39–42]. The most important finding in the present study was that neither normal weight and overweight, nor obesity was significantly predictive of 30-day mortality or 30-day MACO.

  • Planned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention

    2006, American Journal of Cardiology
    Citation Excerpt :

    Moreover, this difference was not observed in REPLACE-1, where GP IIb/IIIa inhibition was used consistently with bivalirudin, suggesting an important role for GP IIb/IIIa inhibitors in subpopulations of smokers who undergo PCI. In our study, we found no significant differences in 30-day ischemic event rates between current smokers and nonsmokers, despite numerous reports of a smoker’s paradox15–23 and more favorable baseline characteristics of the current smokers (unpublished data). Compared with nonsmokers, smokers in our study were younger and developed fewer co-morbidities and coronary risk factors, with the exception of previous MI (Table 1).

View all citing articles on Scopus
1

From the Department of Cardiology, Hiroshima City Hospital.

View full text